Want to see IN:MKPL full AI Analyst Report?

M K Proteins Limited (MKPL) Price & Analysis

0 Followers

MKPL Stock Chart & Stats

₹6.89

-₹0.11(-1.36%)

At close: Jan 08 4:00 PM EST

₹6.89

-₹0.11(-1.36%)

Day’s Range― - ―

52-Week Range₹3.80 - ₹8.84

Previous CloseN/A

Volume181.52K

Average Volume (3M)20.59K

Market Cap

₹1.55B

Enterprise Value₹2.22B

Total Cash (Recent Filing)₹4.38M

Total Debt (Recent Filing)₹371.38M

Price to Earnings (P/E)23.2

Beta0.99

Next Earnings

Aug 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.18

Shares Outstanding375,372,000

10 Day Avg. Volume17,806

30 Day Avg. Volume20,591

Financial Highlights & Ratios

PEG Ratio-1.18

Price to Book (P/B)1.92

Price to Sales (P/S)0.38

P/FCF Ratio76.87

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue Rebound (FY2026)A robust FY2026 revenue rebound indicates renewed demand and the company's ability to scale sales after a choppy period. Sustained top-line recovery can provide operating leverage, support reinvestment in the business, and create room to repair margins and improve cash flow over the medium term.

Multi-year Revenue Growth MetricA high multi-year revenue growth metric reflects structural expansion of the business base rather than a one-off uptick. Continued revenue expansion supports long-term market share gains, enables fixed-cost absorption, and provides a foundation for margin recovery if the company can better manage costs and pricing.

Improved Leverage And Equity BufferMaterial improvement in leverage and rising equity enhance financial resilience and lower solvency risk over time. A healthier balance sheet increases capacity to fund working capital, invest organically or weather cyclical pressures without immediate refinancing, supporting longer-term operational stability.

Bears Say

Sharp Margin CompressionMaterial margin erosion reduces the company's ability to convert sales into sustainable profits. Low gross and net margins leave little buffer for input-cost inflation or pricing pressure, constrain reinvestment capacity, and make earnings vulnerable to volatility, undermining durable profitability.

Inconsistent And Weak Cash GenerationRepeated negative operating cash flow years and weak free cash flow versus earnings signal fragile cash conversion. Poor cash generation limits internal funding for capex, working capital and debt service, increases reliance on external financing, and raises execution risk across cycles.

Meaningful Absolute Debt ExposureDespite improving ratios, the company's absolute debt level remains material. With compressed margins and uneven cash flow, servicing and refinancing that debt could constrain strategic flexibility, elevate credit risk, and pressure liquidity if profitability fails to stabilize over the medium term.

M K Proteins Limited News

M K Proteins Closes Trading Window Ahead of Q1 FY2026 Results

M K Proteins Limited ( ($IN:MKPL) ) has issued an announcement. M K Proteins Limited has announced the...

29d ago

MKPL

MKPL FAQ

What was M K Proteins Limited’s price range in the past 12 months?

M K Proteins Limited lowest stock price was ₹3.80 and its highest was ₹8.84 in the past 12 months.

What is M K Proteins Limited’s market cap?

M K Proteins Limited’s market cap is ₹1.55B.

When is M K Proteins Limited’s upcoming earnings report date?

M K Proteins Limited’s upcoming earnings report date is Aug 18, 2026 which is in 23 days.

How were M K Proteins Limited’s earnings last quarter?

M K Proteins Limited released its earnings results on May 29, 2026. The company reported ₹0.03 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.03.

Is M K Proteins Limited overvalued?

According to Wall Street analysts M K Proteins Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does M K Proteins Limited pay dividends?

M K Proteins Limited does not currently pay dividends.

What is M K Proteins Limited’s EPS estimate?

M K Proteins Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does M K Proteins Limited have?

M K Proteins Limited has 375,372,000 shares outstanding.

What happened to M K Proteins Limited’s price movement after its last earnings report?

M K Proteins Limited reported an EPS of ₹0.03 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of M K Proteins Limited?

Currently, no hedge funds are holding shares in IN:MKPL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

M K Proteins Limited

M. K. Proteins Limited specializes in the production and commercial activities related to a range of refined vegetable oils and their associated derivatives. The company's diverse offerings include refined varieties such as rice bran, sunflower, cottonseed, soybean, palm, canola, and bleached rice bran oils. Furthermore, it provides by-products like rice bran fatty acid oils, rice bran waxes, gums, and spent earth. The firm also participates in the import and trade of both edible and non-edible oils. Founded in 2012, the company's operations are headquartered in Ambala, India.